Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Journal of Endourology|September 1, 2011
Supine versus prone position during percutaneous nephrolithotomy: a report from the clinical research office of the endourological society percutaneous nephrolithotomy global studyJosé G Valdivia, Roberto M Scarpa, Mordechai Duvdevani, et al.Kidney International Reports|February 14, 2022
Long-Term Outcomes of Longitudinal Efficacy Study With Tolvaptan in ADPKDEiji Higashihara, Kikuo Nutahara, Masayuki Itoh, et al.Kidney International Reports|September 21, 2020
Estimation of Changes in Kidney Volume Growth Rate in ADPKDEiji Higashihara, Hiroshi Fukuhara, John Ouyang, et al.Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|April 15, 2008
[Comparison of clinical results between TUR-P and holmium laser enucleation of the prostate (HoLEP) based on the initial experience]Toshihide Shishido, Kaori Enomoto, Naoyuki Fujita, et al.Anticancer Research|July 31, 2014
Zoledronic acid improves clinical outcomes in patients with bone metastatic hormone-naïve prostate cancer in a multicenter clinical trialTakatsugu Okegawa, Masao Higaki, Tetsuo Matsumoto, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|June 27, 2021
PKD1-Associated Arachnoid Cysts in Autosomal Dominant Polycystic Kidney DiseaseKaori Shigemori, Eiji Higashihara, Masayuki Itoh, et al.Clinical Journal of the American Society of Nephrology : CJASN|September 10, 2011
Tolvaptan in autosomal dominant polycystic kidney disease: three years' experienceEiji Higashihara, Vicente E Torres, Arlene B Chapman, et al.Clinical and Experimental Nephrology|October 7, 2017
A potentially crucial role of the PKD1 C-terminal tail in renal prognosisEiji Higashihara, Shigeo Horie, Moritoshi Kinoshita, et al.Molecular Cancer Therapeutics|May 22, 2016
Afatinib against Esophageal or Head-and-Neck Squamous Cell Carcinoma: Significance of Activating Oncogenic HER4 Mutations in HNSCCYu Nakamura, Yosuke Togashi, Hirokazu Nakahara, et al.Plos One|November 12, 2016
Technical Evaluation: Identification of Pathogenic Mutations in PKD1 and PKD2 in Patients with Autosomal Dominant Polycystic Kidney Disease by Next-Generation Sequencing and Use of a Comprehensive New Classification SystemMoritoshi Kinoshita, Eiji Higashihara, Haruna Kawano, et al.Pageof 7